William Blair Initiates Coverage on Perrigo (PRGO) with an Outperform
PRGO Hot Sheet
Rating Summary:8 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 7 | New: 22
William Blair initiates coverage on Perrigo (Nasdaq: PRGO) with an Outperform.
To see more analyst ratings on PRGO Click Here.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products.
To see more analyst ratings on PRGO Click Here.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products.
You May Also Be Interested In
- Perrigo Company To Present At Upcoming Healthcare Conferences
- Goldman Sachs Cuts Numbers on Tiffany & Co. (TIF) after Weak Q1, Guidance
- Oppenheimer Starts Callidus Software (CALD) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
